天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
Beijing Biosynthesis Biotechnology Co Ltd
Firmenname:
Beijing Biosynthesis Biotechnology Co Ltd
Telefon:
400-9019800
E-Mail:
sales@bioss.com.cn
Nationalit?t:
China
URL:
www.biosschina.com
Produkte insgesamt:
6102
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
Produktkatalog
ADA
N-carbamoylmethyliminodi(essigsure)
C6H10N2O5
Nesprin 1
Syntrophin-2
ACVRL1
C29H39NO9
PRG2
ITPKA
PHF-tau
CSP
CuH10O9S
Striatin 3
HBS1L
GSK3A
PRAME
Phospho-PIM1 (Ser99)
Phospho-FoxO1 (Ser329)
CKLFH6
phospho-JAK2 (Tyr1007+Tyr1008)
Metallothionein 3
NPRL3
BBC3/PUMA
DHX37
Angiotensin II
C50H71N13O12
Recombinant Human CD3D Protein, C-Fc
phospho-MARK4 (Ser423)
Galectin 7
CTNNBL1
AKT3(phospho-Y473)
IKK gamma
Indeno[1,2,3-cd]pyren
C22H12
ROM-K/Kcnj1
PURA
Tyrosinase
P53(phospho-S315)
Cathepsin L(light chain)
GRB7
Cdc6
HMGCL
SLC12A5 Antibody Blocking Peptide
FBXO4
CDKN1A/p21
IDI1
Recombinant human IL-13 protein, N-His-Avi (HEK293)
Phospho-Estrogen Receptor alpha (Tyr537)
CD43
Arg-vasopressin
C46H65N15O12S2
CXCL2 Antibody Blocking Peptide
GFAP
MRPS21
TBX1
GAL
Galactose
C6H12O6
ZNF575
Styk1
MCM-BP
Phospho-PKR (Thr446)
CEACAM21
S100A4
Thrombin heavy chain
DECR1
API5
STAT4
METTL4
DYNLT1
TFPI
Recombinant Human ENPP2 Protein, N-His
CD44
lamin B1
CCDC65
NANS
5-HTR2B
Phospho-Tie2 (Ser1119)
Nkx6.2
C9orf72
DFNB31
PAMCI/RASF9
ZDHHC13/HIP14L
COBL
SPANX
phospho-MAP4 (Ser941)
MEK1 + MEK2
Proteasome 20S C2
TFR2
TPPP
PTPD1
SARS-CoV-2 (2019-nCoV) Nucleocapsid
ALPPL2
ANGPTL8
Cyclin D1
C43H71N9O11S2
LASS5
MLX
LHX6
CNTN5
GCNT6
alpha smooth muscle Actin
MCSF Receptor Antibody Blocking Peptide
FAM46C
Nodal
Myosin 1C
Ceramide synthase 2
Mouse Anti-Rat IgG H&L
Cubilin
PRKRIR
ELAVL1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
Copyright 2019 ? ChemicalBook. All rights reserved